Intravenous Infusions is trading 10% up at GHS 0.66, extending a strong rally that has seen consecutive daily gains of approximately 8–10% since July 17, 2026.
- The move appears driven by sustained momentum and speculative interest rather than fundamental shifts, as no fresh company-specific news or disclosures have been identified.
- The price action occurs alongside a generally positive global equity backdrop and rising local Ghana Stock Exchange indices.